Relay Therapeutics RLAY
NASDAQ RLAY
$18.33 -0.12 (-0.65%)
As of: Oct 21, 2026 · 3:27 PM EDT

Relay Therapeutics (RLAY) Acquisitions (2021)

Updated

Relay Therapeutics (RLAY) reported Acquisitions of $83,000 for Q4 2021, unchanged from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Acquisitions (2021) Analysis & Trends

For FY2021, Relay Therapeutics posted Acquisitions of $25.3 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn -
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn -
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn -
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn -
10 Relay Therapeutics 3.72 Bn 3.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 83,000.00
Sep 30, 2021 83,000.00
API Access

Relay Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RLAY&period=max&api_key=YOUR_API_KEY